Swiss firm Lonza said Wednesday it will open a new production line for the drug substance in Moderna’s COVID-19 vaccine, making it possible to churn out […]
Reports of potentially higher rates of vaccine hesitancy among Māori and Pacific populations have seen the government target COVID-19 vaccine and information campaigns at those communities.